Matthew K. Szot
CIK: 0001401385
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 15, 2026SNES
SenesTech, Inc.
Award(A)DirectStock Option (right to buy)
100K shares- - Dec 29, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct9.9K shares at avg. $6.97$69K - Dec 4, 2025IVF
INVO Fertility, Inc.
Other(J)Direct3 shares- - Dec 3, 2025IVF
INVO Fertility, Inc.
Sale(S)Direct4 shares at avg. $1.52$6.08 - Nov 14, 2025SNES
SenesTech, Inc.
Sale(S)Direct1 shares at avg. $2.75$2.75 - Oct 27, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $13.99$25K - Oct 24, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $13.99$25K - Oct 13, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $14.07$25K - Oct 9, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct1.7K shares at avg. $13.99$24K - Oct 6, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct107 shares at avg. $13.99$1K - Oct 1, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct1.7K shares at avg. $13.99$24K - Sep 29, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct100 shares at avg. $14.00$1K - Sep 25, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct10.9K shares at avg. $14.05$153K - Sep 24, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $14.00$21K - Aug 28, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct400 shares at avg. $14.00$6K - Aug 27, 2025CVKD
Cadrenal Therapeutics, Inc.
Sale(S)Direct1.6K shares at avg. $13.99$22K - Aug 26, 2025IVF
INVO Fertility, Inc.
Award(A)DirectStock Option (right to buy)
45K shares- - Jan 23, 2025CVKD
Cadrenal Therapeutics, Inc.
Award(A)DirectStock Options
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  SNES SenesTech, Inc. | Award(A) Stock Option (right to buy) | 100,000 | - | - | Direct |
| Dec 29, 2025 |  CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 9,933 | $6.97 | $69,233 | Direct |
| Dec 4, 2025 |  IVF INVO Fertility, Inc. | Other(J) | 3 | - | - | Direct |
| Dec 3, 2025 | IVF INVO Fertility, Inc. | Sale(S) | 4 | $1.52 | $6 | Direct |
| Nov 14, 2025 | SNES SenesTech, Inc. | Sale(S) | 1 | $2.75 | $3 | Direct |
| Oct 27, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 1,800 | $13.99 | $25,182 | Direct |
| Oct 24, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 1,800 | $13.99 | $25,182 | Direct |
| Oct 13, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 1,800 | $14.07 | $25,326 | Direct |
| Oct 9, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 1,693 | $13.99 | $23,685 | Direct |
| Oct 6, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 107 | $13.99 | $1,497 | Direct |
| Oct 1, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 1,700 | $13.99 | $23,783 | Direct |
| Sep 29, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 100 | $14.00 | $1,400 | Direct |
| Sep 25, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 10,900 | $14.05 | $153,182 | Direct |
| Sep 24, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 1,500 | $14.00 | $20,993 | Direct |
| Aug 28, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 400 | $14.00 | $5,600 | Direct |
| Aug 27, 2025 | CVKD Cadrenal Therapeutics, Inc. | Sale(S) | 1,600 | $13.99 | $22,392 | Direct |
| Aug 26, 2025 | IVF INVO Fertility, Inc. | Award(A) Stock Option (right to buy) | 45,000 | - | - | Direct |
| Jan 23, 2025 | CVKD Cadrenal Therapeutics, Inc. | Award(A) Stock Options | 50,000 | - | - | Direct |
1-18 of 18 transactions
About Szot Matthew K
Szot Matthew K (SEC CIK 0001401385) files insider reports with the SEC as Director of SenesTech, Inc. (SNES), Chief Financial Officer of Cadrenal Therapeutics, Inc. (CVKD) and Director of INVO Fertility, Inc. (IVF).
Signal8 holds 12 ownership filings by Szot Matthew K, all Form 4s, filed between Jan 24, 2025 and Jun 17, 2026. Those filings report 18 transactions, from Jan 23, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Szot Matthew K's filings is in SURPRISE, AZ.
Recent filings by Szot Matthew K
- Jun 15, 2026: Grant or award of SNES derivative securities (Form 4, code A).
- Dec 29, 2025: Open-market sale of CVKD shares (Form 4, code S).
- Dec 4, 2025: Other transaction of IVF shares (Form 4, code J).
- Dec 3, 2025: Open-market sale of IVF shares (Form 4, code S).
- Nov 14, 2025: Open-market sale of SNES shares (Form 4, code S).
Other insiders filing for SenesTech, Inc. (SNES)
- GLENBROOK CAPITAL MANAGEMENT, 10% Owner
- Edell Michael, Chief Executive Officer
- Moss Joshua Matthew, Director
- Grandinetti Phillip Nicholas III, Director
- Leach Jacob Steven, Director
- CHESTERMAN THOMAS C, CFO & Treasurer